EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 26 filers reported holding EVOGENE LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $191,000 | +7.3% | 230,606 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $178,000 | -40.7% | 230,606 | 0.0% | 0.01% | -33.3% |
| Q1 2022 | $300,000 | -20.6% | 230,606 | 0.0% | 0.01% | -18.2% |
| Q4 2021 | $378,000 | -37.9% | 230,606 | 0.0% | 0.01% | -35.3% |
| Q3 2021 | $609,000 | -60.9% | 230,606 | -49.4% | 0.02% | -62.2% |
| Q2 2021 | $1,557,000 | -58.4% | 455,340 | -38.6% | 0.04% | -61.9% |
| Q1 2021 | $3,740,000 | +68.0% | 742,027 | +56.7% | 0.12% | +35.6% |
| Q4 2020 | $2,226,000 | -8.8% | 473,657 | -23.2% | 0.09% | -37.0% |
| Q3 2020 | $2,442,000 | +414.1% | 616,616 | +29.9% | 0.14% | +360.0% |
| Q2 2020 | $475,000 | -2.9% | 474,682 | +14.5% | 0.03% | -47.4% |
| Q1 2020 | $489,000 | -22.4% | 414,682 | 0.0% | 0.06% | +32.6% |
| Q4 2019 | $630,000 | -3.8% | 414,682 | 0.0% | 0.04% | -23.2% |
| Q3 2019 | $655,000 | -1.9% | 414,682 | 0.0% | 0.06% | -5.1% |
| Q2 2019 | $668,000 | +165.1% | 414,682 | +201.1% | 0.06% | +210.5% |
| Q1 2019 | $252,000 | -7.7% | 137,739 | 0.0% | 0.02% | -20.8% |
| Q4 2018 | $273,000 | -36.2% | 137,739 | 0.0% | 0.02% | -25.0% |
| Q3 2018 | $428,000 | +8.6% | 137,739 | 0.0% | 0.03% | +18.5% |
| Q2 2018 | $394,000 | -9.8% | 137,739 | 0.0% | 0.03% | -18.2% |
| Q1 2018 | $437,000 | +3.3% | 137,739 | 0.0% | 0.03% | +10.0% |
| Q4 2017 | $423,000 | -30.9% | 137,739 | 0.0% | 0.03% | -25.0% |
| Q3 2017 | $612,000 | -12.2% | 137,739 | 0.0% | 0.04% | -27.3% |
| Q2 2017 | $697,000 | -5.4% | 137,739 | 0.0% | 0.06% | +3.8% |
| Q1 2017 | $737,000 | +5.0% | 137,739 | 0.0% | 0.05% | +6.0% |
| Q4 2016 | $702,000 | -0.8% | 137,739 | +24.2% | 0.05% | -2.0% |
| Q3 2016 | $708,000 | +2.3% | 110,939 | 0.0% | 0.05% | -10.5% |
| Q2 2016 | $692,000 | -4.3% | 110,939 | 0.0% | 0.06% | -6.6% |
| Q1 2016 | $723,000 | -19.0% | 110,939 | 0.0% | 0.06% | -9.0% |
| Q4 2015 | $893,000 | -2.4% | 110,939 | 0.0% | 0.07% | +1.5% |
| Q3 2015 | $915,000 | -6.7% | 110,939 | 0.0% | 0.07% | +8.2% |
| Q2 2015 | $981,000 | +0.3% | 110,939 | 0.0% | 0.06% | 0.0% |
| Q1 2015 | $978,000 | -4.3% | 110,939 | 0.0% | 0.06% | -16.4% |
| Q4 2014 | $1,022,000 | -18.5% | 110,939 | +16.4% | 0.07% | -37.6% |
| Q3 2014 | $1,254,000 | -19.7% | 95,324 | 0.0% | 0.12% | -14.0% |
| Q2 2014 | $1,561,000 | -14.0% | 95,324 | 0.0% | 0.14% | -3.5% |
| Q1 2014 | $1,816,000 | -7.6% | 95,324 | -4.7% | 0.14% | -18.0% |
| Q4 2013 | $1,965,000 | – | 100,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 293,057 | $481,000 | 0.20% |
| Eidelman Virant Capital | 113,000 | $185,000 | 0.07% |
| Susquehanna International Group Ltd. | 31,753 | $55,000 | 0.02% |
| ARK Investment Management | 3,611,842 | $6,020,000 | 0.02% |
| Senvest Management, LLC | 230,606 | $378,000 | 0.01% |
| Csenge Advisory Group | 28,700 | $96,000 | 0.01% |
| MGO ONE SEVEN LLC | 25,340 | $42,000 | 0.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 25,826 | $42,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $16,000 | 0.00% |
| Vident Investment Advisory, LLC | 49,786 | $82,000 | 0.00% |